Virtual Overdose Response

Status Withdrawn

Clinical Trial Summary

To help prevent deaths in populations that cannot or will not access physical safer consumption services in Alberta, which may disproportionately include women and those who are not able to self-inject (Potier et al., 2014) the investigators propose to provide virtual (phone-based) supervised consumption services, staffed by people with lived experience.

Clinical Trial Description

Designed as a small open label clinical study to demonstrate proof of concept which will follow CONSORT guidelines, the investigators aim to recruit approximately 15 people who are currently using illicit substances and who currently use opioids (illicit or prescription - non-medically). The sample size of 15 balances pragmatic issues (difficulty in recruiting people who are actively using illicit substances) and the need to have a good sample of the population. These participants will be interviewed by the research coordinator in person prior to intervention initiation to determine baseline use; history of overdose; and current harm reduction activities (see appendix). They will then be asked to call the intervention number if they are going to be using alone (see appendix for call flow). Each time a participant dials the number, the operator will gather (as part of the intervention) the address the participant is at, their name/pseudonym and a phone number that can be used as a call back number in case the call is disconnected. The phone line operator will then ask a) what they planned on using, b) the method of use, c) if the participant is using safe sterile supplies (and provide information on where they can get new supplies in their community), and d) if they have a naloxone kit (overdose reversal kit) available. They will then inform the participant that they will be checking in on them every 5 - 10 minutes and if they do not respond, they will call emergency medical services for them. If the participant responds to each verbal prompt (calling their name) over a minimum of 30 minutes, the operator will let them know that they are disconnecting the call. The operator will offer to connect the participant to other health services, such as the location of new supplies, social services, addiction treatment and opioid agonist therapy. If the participant fails to respond to a prompt (or the call is disconnected and is not able to be reconnected), the operator will contact the dispatch supervisor and the process for emergency services dispatch will be initiated. ;

Study Design

Related Conditions & MeSH terms

Drug Overdose

Clinical Trial Details

NCT number	NCT04391192
Study type	Interventional
Source	AHS Cancer Control Alberta
Contact
Status	Withdrawn
Phase	N/A
Start date	September 2020
Completion date	February 2021

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04070521` - EEG Monitoring in the Emergency Department
Completed	`NCT04372238` - The Rhode Island Prescription and Illicit Drug Study	N/A
Completed	`NCT02924454` - Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol.	Phase 4
Completed	`NCT02282306` - Phone Interview to Prevent Recurring Opioid Overdoses	N/A
Not yet recruiting	`NCT01912573` - Nasal Naloxone for Narcotic Overdose	Phase 4
Completed	`NCT04091659` - Use of Virtual Reality for Overdose Management Educational Trainings	N/A
Recruiting	`NCT05517668` - Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose	Phase 2
Completed	`NCT02572089` - Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers	Phase 1
Completed	`NCT02152397` - Safety and Health Intervention Project	N/A
Active, not recruiting	`NCT05096429` - Preventing Overdose Using Information and Data From the Environment	N/A
Recruiting	`NCT03845699` - Development of an Algorithm That Predicts Hypoventilation Due to an Opioid Overdose
Completed	`NCT03840018` - Effectiveness of a Postal Intervention to Improve the Use of PPI	N/A
Completed	`NCT03087149` - Monitored vs Standard Supplementation of Vitamin D in Preterm Infants	N/A
Recruiting	`NCT05657106` - Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk	N/A
Completed	`NCT02598856` - Bioavailability of Nasal Naloxone and Injected Naloxone Compared	Phase 1
Completed	`NCT02158117` - Bioavailability of a New Formulation of Nasal Naloxone for Prehospital Use	Phase 1
Recruiting	`NCT05146336` - CytOSorb TreatMent Of Critically Ill PatientS Registry
Not yet recruiting	`NCT02733822` - Buccal Versus Injectable Naloxone: a Phase I Healthy Volunteer Study	Phase 1
Not yet recruiting	`NCT06327061` - Social Network Overdose Prevention and Education Intervention	N/A
Active, not recruiting	`NCT05308303` - AI to Improve Data From Danish Cardiac Arrest Registry

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.